Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078286 · ClinicalTrials.gov registry record · Phase 2
Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 469
- Enrollment target
NCT00078286 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 469 participants.
The verdict
NCT00078286, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 469 participants
- Enrollment target
Study Summary
This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.
Interventions
- DRUG Placebo
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00078286
The ClinicalTrials.gov registry entry for NCT00078286 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 469 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00078286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00078286 about?
NCT00078286 is a clinical study titled "Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure". This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.
What is the current status of trial NCT00078286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 469 participants. The study started on 2003-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00078286?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT00078286?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.